Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Communication is the key to the participatory medicine model

Participatory medicine is an emerging healthcare movement that champions patient preference and values as equal to medical expertise. Following participatory medicine processes means that everyone involved in a healthcare decision...

- PMLiVE

Rapid career progression at Porterhouse Medical

We are delighted to announce another promotion within our scientific services team.

Porterhouse Medical Group

Sanofi reception

Sanofi, Regeneron offer price cut for cholesterol drug Praluent

Amgen’s Repatha also struggled to secure reimbursement at its launch price point

AstraZeneca AZ

AZ pushes back data read-out from MYSTIC lung cancer trial

The delay could further undermine confidence in a positive outcome

Value proposition development

Pharma companies need to demonstrate value to the NHS, so developing a clear statement to articulate that value to customers is a vital element of the marketing mix.

Dovetail

Joined-up thinking on anaemia

Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’s quality of life, but it’s often under-treated.

Dovetail

- PMLiVE

CDM develops creative global collaboration model

The healthcare advertising agency will offers a global collaborative approach from its base in the UK capital

Pharma and NHS working together for patients – the IBD Registry Industry Working Group

We hear a lot from pharma about patient-centricity these days, and rightly so. But there are many ways of putting this important principle into practice, and they don’t have to...

Dovetail

- PMLiVE

Let’s change the conversation about cancer

The changing identity of cancer

- PMLiVE

MSD launches EU’s first biosimilar Herceptin in UK

Ontruzant is set to be strong competition for Roche’s blockbuster

- PMLiVE

Novartis pushes ‘virtual’ clinical trial concept

Teams up with Science 37 to run ten digital-based trials over the next three years

Open Health creates new role

Gavin Jones joins the agency as its director of rare disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links